Neil Gallagher - President, Head of R&D at Syndax Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Head of R&D
Stock Symbol
SNDX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Neil Gallagher since 9/17/2023

Holdings reported by Neil Gallagher for Syndax Pharmaceuticals Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Options (Right to buy) 69.4K $1.55M $22.28 Feb 7, 2024 Direct Common Stock
Common Stock 47.8K $873K $18.27 Feb 7, 2024 Direct

Transactions reported by Neil Gallagher for Syndax Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.